BCL2 and osteosarcoma: Furthermore, western blot results showed that miR-29a significantly inhibited the expression of NFIA, anti-apoptosis protein Bcl-2, and EMT marker N-cadherin, but promoted the expression of pro-apoptotic protein Bax and EMT marker E-cadherin in osteosarcoma cells.